Comments

Artelo Biosciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Artelo Biosciences (ARTL) operate in?

Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

ARTLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.9701

-0.02-2.02%

At close: -

$0.9900

0.022.06%

After Hours: 7:56 PM EDT

Artelo Biosciences (ARTL) Forecast

News Earnings Artelo Biosciences (ARTL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Artelo Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ARTL | Benzinga

Explore Artelo Biosciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ARTL.

Open	$0.96
Close	$0.97
Volume / Avg.	19.64K / 28.50K
Day Range	$0.96 - $0.98
52 Wk Range	0.91 - 1.70
Market Cap	$3.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	0.42%
Days to Cover	1

Recent News

EXCLUSIVE: Artelo Biosciences Concludes First Cohort Of Healthy Volunteers Of FABP Inhibitor Program

Artelo Biosciences advances its pipeline with ART26.12 for neuropathic pain and ART27.13 for cancer-related anorexia, targeting 2025 milestones.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.96
Close	$0.97
Volume / Avg.	19.64K / 28.50K
Day Range	$0.96 - $0.98
52 Wk Range	0.91 - 1.70
Market Cap	$3.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	0.42%
Days to Cover	1

About Artelo Biosciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is e...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Artelo Biosciences (ARTL) stock?

You can purchase shares of Artelo Biosciences (NASDAQ:ARTL) through any online brokerage.

View our list of the best stock brokerages

Who are Artelo Biosciences (ARTL) competitors?

Other companies in Artelo Biosciences’s space includes: 60 Degrees (NASDAQ:SXTP), Akanda (NASDAQ:AKAN), Universe Pharmaceuticals (NASDAQ:UPC), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Hepion Pharmaceuticals (NASDAQ:HEPA).

What is the forecast, or price target, for Artelo Biosciences (ARTL) stock?

Artelo Biosciences has a consensus price target of $19.25.

What is the current price for Artelo Biosciences (ARTL)?

The stock price for Artelo Biosciences (NASDAQ: ARTL) is $0.99 last updated March 11, 2025 at 7:56 PM EDT.

Does Artelo Biosciences (ARTL) pay a dividend?

There are no upcoming dividends for Artelo Biosciences.

When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?

Artelo Biosciences’s Q1 earnings are confirmed for Monday, May 12, 2025.

Is Artelo Biosciences (ARTL) going to split?

There is no upcoming split for Artelo Biosciences.

What sector and industry does Artelo Biosciences (ARTL) operate in?

Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.